Closing Bell: Nervgen Pharma Corp down on Tuesday (NGEN)

Today, Nervgen Pharma Corp shares closed at $2.35 after opening the day at $2.34. Intraday prices ranged from a low of $2.23 to a high of $2.49.

The price decreased -0.42% from the previous day's close of $2.36.

During the day across North America, the TSX Composite closed -0.83% at 21887.34, the S&P 500 closed 0.26% at 5360.79, the Dow Jones Industrial Average closed 0.18% at 38868.04 and the Nasdaq Composite closed 0.35% at 17192.53.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

Trading volume was 261,207 on 403 total trades. On average, Nervgen Pharma Corp has traded 171,165 shares in the last five days and 90,205 year-to-date.

The TSX-V market on the whole today saw 2,014 price advancers against 3,108 declines and 138 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have soared 37.43% in the last year, while in 2024, they have dipped -12.96%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $165.03 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..